Table 1.
Patient demographics and clinical variables by HIV status for cervical cancer patients seen at the Cancer Diseases Hospital, Lusaka, Zambia from 2008 to 2012
| N (%) | HIV-positive n=224 (41.7%) | HIV- negative n=313 (58.3%) | Total n=537 | P-value* |
|---|---|---|---|---|
| Age (years) | ||||
| Mean (SD) | 42.4 (8.4) | 52.4 (11.8) | 48.3 (11.6) | <0.0001 |
| Baseline FIGO stage | ||||
| I (%) | 35 (15.6) | 42 (13.4) | 77 (14.3) | |
| II (%) | 189 (84.4) | 271 (86.6) | 460 (85.7) | 0.47 |
| Treatment completion | ||||
| 1–3 cycles chemotherapy†(%) | 109 (48.7) | 167 (53.4) | 276 (51.4) | 0.08 |
| EBRT(%) | 177 (79) | 239 (76.4) | 416 (77.5) | 0.02 |
| Brachytherapy (%) | 185 (82.6) | 264 (84.3) | 449 (83.6) | 0.05 |
| BRT + EBRT (%) | 176 (78.6) | 230 (73.4) | 406 (75.6) | 0.70 |
| 1–3 chemo +EBRT (%) | 106 (47.3) | 147 (47) | 253 (47.1) | 0.41 |
| 1–3 chemo+BRT (%) | 108 (48.2) | 159 (50.8) | 267 (49.7) | 0.14 |
| 1–3 chemo+EBRT+ BRT (%) | 106 (47.3) | 143 (45.7) | 249 (46.4) | 0.58 |
| Progressive disease‡ (%) | 57 (25.4) | 75 (23.9) | 132 (24.6) | 0.33 |
All percentages in table 1 are column percentages and patients may be included in multiple groups.
There were 52 patients (28 HIV-positive and 24 HIV-negative) who had all missing treatment information.
*
P-value for t-test for continuous variables and Chi-square test for categorical variables.
†
22.5% missing (32% HIV-positive and 16% HIV-negative).
‡
8.4% missing in outcome variable (22.3% HIV-positive and 15.6% HIV-negative).
BRT, brachytherapy; chemo, chemotherapy; EBRT, external beam radiation; FIGO, International Federation of Gynecology and Obstetrics.